Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cristea

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Science (New York, N.Y.)|March 19, 2026
Agroseismology and the impact of farming practices on soil hydrodynamicsQibin Shi, David R Montgomery, Abigail L S Swann, et al.
Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavityMihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian CancerLarissa A Meyer, Angel M Cronin, Charlotte C Sun, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2018
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumorsStephen V Liu, Susan G Groshen, Karen Kelly, et al.
Journal of Ovarian Research|July 17, 2023
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancerA W Adamson, Y C Ding, L Steele, et al.
Research Square|March 3, 2023
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian CancerA W Adamson, Y C Ding, L Steele, et al.
Romanian Journal of Virology|January 1, 1997
Clinical manifestations in the West Nile virus outbreakE Ceauşu, S Erşcoiu, P Calistru, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Science (New York, N.Y.)|March 19, 2026
Agroseismology and the impact of farming practices on soil hydrodynamicsQibin Shi, David R Montgomery, Abigail L S Swann, et al.
Frontiers in Oncology|March 28, 2019
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)Karen L Reckamp, Paul H Frankel, Nora Ruel, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2019
A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavityMihaela C Cristea, Paul Frankel, Timothy Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian CancerLarissa A Meyer, Angel M Cronin, Charlotte C Sun, et al.
Gynecologic Oncology|January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancerMihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2018
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumorsStephen V Liu, Susan G Groshen, Karen Kelly, et al.
Journal of Ovarian Research|July 17, 2023
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancerA W Adamson, Y C Ding, L Steele, et al.
Research Square|March 3, 2023
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian CancerA W Adamson, Y C Ding, L Steele, et al.
Romanian Journal of Virology|January 1, 1997
Clinical manifestations in the West Nile virus outbreakE Ceauşu, S Erşcoiu, P Calistru, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Pageof 6